Oocyte Competence

2

Review clinical trials related to Oocyte Competence. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture

This study aims to assess the effect of age of the male partner and the reproductive ability of sperm prepared via sperm selection devices (Zymot) compared to routine embryologist selected sperm after density gradient centrifugation (DGC) preparation for intracytoplasmic sperm injection (ICSI) in patients undergoing in vitro fertilization treatment (IVF) of their infertility.

Participants needed: 100
Trial details
Age: 18-41Biological sex: FemaleType: InterventionalSponsor: Reproductive Medicine Associates of New JerseyUpdated: Jun 3, 2026Locations: 1
Eligibility criteria

Undergoing first IVF cycle [+8]

Contraindication to IVF [+11]

Status: Recruiting

Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT)

The purpose of this study is to investigate the potential of autologous adipose stem cell (ASC) mitochondrial transfer (ASCENT) to oocytes along with intracytoplasmic sperm injection (ICSI)as a means of enhancing embryo development and improving the success rate of in patients with a history of multiple IVF failures. Embryo quality plays a crucial role in determining the success of assisted reproductive technologies and directly contributes to repeated pregnancy failures. Several factors, including age, physiological conditions, genetics, and environmental influences, can significantly impact embryo quality. Oocytes, the largest cells in the human body, are heavily reliant on mitochondria. Mitochondria's role in providing energy for oocytes is crucial, and insufficient energy production has been linked to poor oocyte and embryo quality. Some human studies have shown that increasing oocyte mitochondrial mass can improve embryo quality in patients who have experienced repeated IVF failures.

Participants needed: 20
Trial details
Age: 29-39Biological sex: FemaleType: InterventionalSponsor: Sunkaky Medical CooperationUpdated: Jul 17, 2025Locations: 1
Eligibility criteria

Having at least three previous failed IVF trial [+6]

Ovarian endometriosis with Chocolate cysts (American Fertility Society (AFS)) cl... [+6]